Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-07

Clinical Trial Update: A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists. [Phase 2]

View source ↗

Summary

Phase 2 study assessing abuse potential of oxymorphone compared with other mu opioid agonists in opioid use disorder; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxymorphone (oxymorphone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2023-09-07